EBSAM
ZBH icon

Eubel Brady & Suttman Asset Management’s Zimmer Biomet ZBH Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Sell
297,344
-2,746
-0.9% -$241K 3.04% 12
2026
Q1 		$27.1M Buy
300,090
+26,615
+10% +$2.44M 3.21% 7
2025
Q4 		$24.6M Sell
273,475
-19,274
-7% -$1.83M 2.76% 12
2025
Q3 		$28.8M Buy
292,749
+1,584
+0.5% +$157K 3.31% 8
2025
Q2 		$26.6M Buy
291,165
+53,105
+22% +$5.13M 3.36% 9
2025
Q1 		$26.9M Buy
238,060
+4,604
+2% +$493K 3.55% 7
2024
Q4 		$24.7M Buy
233,456
+3,128
+1% +$336K 3.25% 8
2024
Q3 		$24.9M Buy
230,328
+953
+0.4% +$104K 3.24% 8
2024
Q2 		$24.9M Buy
229,375
+6,372
+3% +$751K 3.6% 8
2024
Q1 		$29.4M Sell
223,003
-1,357
-0.6% -$170K 3.74% 5
2023
Q4 		$27.3M Buy
224,360
+34,669
+18% +$3.87M 3.62% 6
2023
Q3 		$21.3M Buy
189,691
+10,806
+6% +$1.37M 3.11% 11
2023
Q2 		$26M Buy
178,885
+1,037
+0.6% +$141K 3.59% 3
2023
Q1 		$23M Buy
177,848
+2,811
+2% +$353K 3.33% 12
2022
Q4 		$22.3M Buy
175,037
+3,229
+2% +$375K 3.59% 7
2022
Q3 		$18M Buy
171,808
+7,160
+4% +$786K 3.21% 10
2022
Q2 		$17.3M Buy
164,648
+76,170
+86% +$9.04M 3.46% 11
2022
Q1 		$11.3M Buy
+88,478
New +$10.7M 2.08% 24
2021
Q3 		– Sell
-112
Closed -$17K – 359
2021
Q2 		$17K Buy
+112
New +$18.1K ﹤0.01% 481

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's ZBH Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management reduced its Zimmer Biomet (ZBH) stake by 0.92% in Q2 2026, selling an estimated $241K and leaving 297,344 shares worth $25.6M. The position accounts for 3.04% of the portfolio, ranked #12.

Eubel Brady & Suttman Asset Management first reported a position in ZBH in Q2 2021 and has held it in 19 quarters since. The position peaked at $29.4M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Eubel Brady & Suttman Asset Management held 297,344 shares of Zimmer Biomet worth $25.6M as of Q2 2026.
  • Eubel Brady & Suttman Asset Management sold 2,746 Zimmer Biomet shares in Q2 2026, an estimated $241K.
  • Zimmer Biomet made up 3.04% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #12 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Zimmer Biomet in Q2 2021 and has held it in 19 quarters since.
  • Eubel Brady & Suttman Asset Management's Zimmer Biomet position peaked at $29.4M in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.